Comprehensive Anticancer Compound Evaluation

CB-839, mitomycin C, cryptotanshinone, altretamine, GSK583, liproxstatin-1, spautin-1, PD-1/PD-L1 inhibitor 2, RVX-208, selinexor, ferrostatin-1, diacerein, LY2603618, and patupilone were purchased from Selleckchem (Houston, TX). Cisplatin, carboplatin and oxaliplatin were purchased from Sigma-Aldrich (St. Louis, MO). Olaprib, niraparib, veliparib were purchased from Cayman Chemical (Ann Arbor, MI). As₂O₃ was purchased from BioTang (Lexington, MA). C1–27 is a GSTO1 inhibitor previously identified and synthesized by our laboratory (5 (link)).

Partial Protocol Preview
This section provides a glimpse into the protocol.
The remaining content is hidden due to licensing restrictions, but the full text is available at the following link: Access Free Full Text.

Xu Y., Bankhead A I.I.I., Tian X., Tang J., Ljungman M, & Neamati N. (2020). Deletion of Glutathione S-Transferase Omega 1 Activates Type I Interferon Genes and Downregulates Tissue Factor. Cancer research, 80(17), 3692-3705.

Publication 2020

CB-839 mitomycin C cryptotanshinone liproxstatin-1 spautin-1 RVX-208 selinexor ferrostatin-1 LY2603618 Cisplatin carboplatin oxaliplatin veliparib

Altretamine As2o3 Carboplatin Cayman Cb 839 Cisplatin Cryptotanshinone Diacerein Ferrostatin 1 Gsk583 Liproxstatin 1 Ly2603618 Mitomycin c Niraparib Oxaliplatin Patupilone Pd l1 inhibitor Rvx 208 Selinexor Spautin 1 Veliparib

Corresponding Organization :

Other organizations : University of Michigan–Ann Arbor

Top 5 similar protocols

Variable analysis

independent variables

CB-839
Mitomycin C
Cryptotanshinone
Altretamine
GSK583
Liproxstatin-1
Spautin-1
PD-1/PD-L1 inhibitor 2
RVX-208
Selinexor
Ferrostatin-1
Diacerein
LY2603618
Patupilone
Cisplatin
Carboplatin
Oxaliplatin
Olaprib
Niraparib
Veliparib
As2O3
C1–27 (a GSTO1 inhibitor)

dependent variables

Not explicitly mentioned

control variables

Not explicitly mentioned

positive controls

Not specified

negative controls

Not specified

Annotations

Based on most similar protocols

Etiam vel ipsum. Morbi facilisis vestibulum nisl. Praesent cursus laoreet felis. Integer adipiscing pretium orci. Nulla facilisi. Quisque posuere bibendum purus. Nulla quam mauris, cursus eget, convallis ac, molestie non, enim. Aliquam congue. Quisque sagittis nonummy sapien. Proin molestie sem vitae urna. Maecenas lorem.

As authors may omit details in methods from publication, our AI will look for missing critical information across the 5 most similar protocols.

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Revolutionizing how scientists
search and build protocols!